Welcome to ProbeChem!Global Supplier of Chemical Probes, Inhibitors & Agonists.
EN | CN

You are here:Home-Chemical Inhibitors & Agonists-Others-Other Targets-ST2 inhibitor XY52
ST2 inhibitor XY52

Chemical Structure : ST2 inhibitor XY52

CAS No.:

ST2 inhibitor XY52

Catalog No.: PC-21150Not For Human Use, Lab Use Only.

ST2 inhibitor XY52 is a specific small molecule inhibitor of soluble suppression of tumorigenesis-2 factor (ST2) with IC5 of 5.68 and 4.59 uM in ST2/IL-33 AlphaLISA and HEK-Blue reporter assays, repsectively.

Packing Price Stock Quantity
50 mg Get quote
100 mg Get quote
200 mg Get quote
1 g Get quote

Bulk size, bulk discount!

E-mail: sales@probechem.com

Tech Support: tech@probechem.com

Purity & Documentation Purity: >98% (HPLC)

Biological Activity

ST2 inhibitor XY52 is a specific small molecule inhibitor of soluble suppression of tumorigenesis-2 factor (ST2) with IC5 of 5.68 and 4.59 uM in ST2/IL-33 AlphaLISA and HEK-Blue reporter assays, repsectively.
ST2 inhibitor XY52 shows 11-fold selectivity over ST2/IL1RAcP(IC50=64.3 uM) in AlphaLISA assay, inhibits more effectively the binding of IL-33 with sST2 than membrane ST2 bound with IL1RAcP.
ST2 inhibitor XY52 shows improved inhibitory activity and metabolic stability in vitro and in vivo than iST2-1 (Cat# PC-35645).
ST2 inhibitor XY52 (5-10 uM) induces dose-dependent reduction in CD4+ and CD8+ T-cell proliferation, with no significant toxicity to human peripheral blood mononuclear cells (PBMCs).
ST2 inhibitor XY52 (40 mg/kg BID, i.p. 21 days) reduces plasma sST2 and IFN-γ levels and GVHD score and extends survival in mice graft versus host disease (GVHD) model.

Physicochemical Properties

M.Wt 499.66
Formula C30H37N5O2
Appearance Solid
CAS No.
Storage
Solide Powder
-20°C 12 Months; 4°C 6 Months
In Solvent
-80°C 6 Months; -20°C 6 Months
Shipping
Solubility

10 mM in DMSO

Chemical Name/SMILES

3-(3-(1-((1-Ethyl-5-(2-methyl-4-nitrophenyl)-1H-pyrrol-2-yl)methyl)pyrrolidin-2-yl)phenyl)-3,8-diazabicyclo[3.2.1]octane

References

1. Xinrui Yuan , et al. ACS Pharmacol Transl Sci. 2023 Aug 16;6(9):1275-1287.

Copyright © 2022 probechem.com. All Rights Reserved. probechem Copyright

Contact Us sales@probechem.com

Bulk Inquiry

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • *Additional Information:

Get Quote

* Indicates a Required FieldYour information is safe with us.

  • *Product name:
  • *Applicant name:
  • *Email address:
  • *Organization name:
  • *Requested quantity:
  • *Country:
  • Additional Information: